# Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients.

> **NCT01875341** · PHASE3 · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 16 (actual)

## Conditions studied

- Type 2 Diabetes
- Diabetic Nephropathy
- Hypertension
- Sleep Apnea

## Interventions

- **DEVICE:** NCPAP; Nasal continuous positive airway pressure.
- **DEVICE:** NCPAP Nasal Continuous Positive Airway Pressure-sub-therapeutic treatment group

## Key facts

- **NCT ID:** NCT01875341
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01875341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01875341, "Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01875341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*